Pnc Financial Services Group, Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $597 - $763	44 Added 7.93%	599 $9,000
Q4 2023 Feb 09, 2024	SELL	$10.11 - $16.54 $2,699 - $4,416	-267 Reduced 32.48%	555 $8,000
Q3 2023 Nov 13, 2023	BUY	$12.46 - $15.48 $2,703 - $3,359	217 Added 35.87%	822 $10,000
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $2,638 - $4,088	-185 Reduced 23.42%	605 $9,000
Q4 2022 Feb 10, 2023	BUY	$14.85 - $19.04 $10,959 - $14,051	738 Added 1419.23%	790 $12,000
Q1 2022 May 12, 2022	BUY	$6.87 - $11.11 $199 - $322	29 Added 126.09%	52 $0
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $61 - $297	8 Added 53.33%	23 $0
Q3 2021 Nov 05, 2021	BUY	$26.46 - $37.15 $396 - $557	15 New	15 $0
Q1 2020 May 08, 2020	SELL	$33.63 - $69.4 $638 - $1,318	-19 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$31.7 - $69.93 $602 - $1,328	19 New	19 $1,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.